The Third Circuit’s recent rejection in Eisai v. Sanofi-Aventis of allegations of anticompetitive exclusive dealing arrangements in the form of a market-share discount program has been described as “another nail in the coffin” of loyalty discount liability. But to what extent did the court’s decision leave the door open to liability in future cases with different (or better) facts? Did it clarify the line between permissible pro-competitive discounting and customer coercion? Our esteemed panelists will discuss (and debate) these and many other questions raised by the decision. Steve Salop will be a panelist on the this topic.
For more information on this event, click here.
CRA Competition economists contribute to article-by-article commentary on the EU Foreign Subsidies Regulation
It gives the European Commission far-reaching powers to scrutinize financial contributions from non-EU governments to companies active in the EU, including in...